Carcinogenic effects of antibiotic residues in meat
Clinical and statistical perspective
Keywords:
antibiotics residues, clinical perspective, statistical perspective, impact, CohorteAbstract
Through this research note we focused on the subject of the link between the use of antibiotics and its residues in the human and animal body and the appearance of tumors. A clinical and statistical perspective is conducted in our note, through examples of literature that have discussed this topic in which the impact of some antibiotics is determined theoretically and the interdiction of some molecules is made in some countries, but in fact and statistically the application of adequate etiological study "cohort" in order to correlate the causes and effects is failed because the conditions of feasibility is incomplete or poorly defined. In vitro studies, modeling and docking are required to confirm or affirm the hypotheses about the subject.
Downloads
References
Chokshi, A., Sifri, Z., Cennimo, D., & Horng, H. (2019). Global contributors to antibiotic resistance. Journal of global infectious diseases, 11(1), 36.
Berghiche, A., Khenenou, T., Kouzi, A., & Labiad, I. (2018). An investigation on the predominant diseases, its diagnosis, and commonly used drugs in the poultry farms in the North-Eastern regions of Algeria. Veterinary world, 11(7), 986.
Sköld, O. (2011). Antibiotics and antibiotic resistance. John Wiley & Sons.
Malfertheiner, P., Sipponen, P., Naumann, M., Moayyedi, P., Mégraud, F., Xiao, S. D., ... & Nyrén, O. (2005). Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Official journal of the American College of Gastroenterology| ACG, 100(9), 2100-2115.
Silver, L. L., & Bostian, K. A. (1993). Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrobial agents and chemotherapy, 37(3), 377-383.
Benigni, R., & Bossa, C. (2011). Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chemical reviews, 111(4), 2507-2536.
Barrett, J. C. (1993). Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environmental health perspectives, 100, 9-20.
Cohen, S. M., & Ellwein, L. B. (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer research, 51(24), 6493-6505.
Pascal, G. (1991). Safety assessment in relation to additives. Food Policy Trends in Europe: Nutrition, Technology, Analysis and Safety, 178.
Westendorf, J., Marquardt, H., & Marquardt, H. (1982). Anthracycline antitumor antibiotics: Their carcinogenicity and their mutagenicity. In Anthracycline antibiotics in cancer therapy (pp. 30-49). Springer, Dordrecht.
Bacanlı, M., & Başaran, N. (2019). Importance of antibiotic residues in animal food. Food and Chemical Toxicology, 125, 462-466.
Jaegerstad, M., & Skog, K. (2005). Genotoxicity of heat-processed foods. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 574(1-2), 156-172.
Dinh, Q. T., Munoz, G., Duy, S. V., Do, D. T., Bayen, S., & Sauvé, S. (2020). Analysis of sulfonamides, fluoroquinolones, tetracyclines, triphenylmethane dyes and other veterinary drug residues in cultured and wild seafood sold in Montreal, Canada. Journal of Food Composition and Analysis, 94, 103630.
Tsai, M. Y., Lin, C. F., Yang, W. C., Lin, C. T., Hung, K. H., & Chang, G. R. (2019). Health risk assessment of banned veterinary drugs and quinolone residues in shrimp through liquid chromatography–tandem mass spectrometry. Applied Sciences, 9(12), 2463.
Khan, M., & Lively, J. A. (2020). Determination of sulfite and antimicrobial residue in imported shrimp to the USA. Aquaculture Reports, 18, 100529.
Hanekamp, J. C., & Bast, A. (2015). Antibiotics exposure and health risks: chloramphenicol. Environmental toxicology and pharmacology, 39(1), 213-220.
Ehrenberg, L., & Osterman‐Golkar, S. (1981). Alkylation of macromolecules for detecting mutagenic agents. Teratogenesis, carcinogenesis, and mutagenesis, 1(1), 105-127.
Bauer, G. (2012). Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer research, 32(7), 2599-2624.
Guengerich, F. P. (2008). Cytochrome p450 and chemical toxicology. Chemical research in toxicology, 21(1), 70-83.
Hansen, L. G., & Shane, B. S. (2019). Xenobiotic metabolism. In Basic environmental toxicology (pp. 49-105). CRC Press.
Lieber, C. S. (1997). Cytochrome P-4502E1: its physiological and pathological role. Physiological reviews, 77(2), 517-544.
Sheweita, S. A. (2000). Drug-metabolizing enzymes mechanisms and functions. Current drug metabolism, 1(2), 107-132.
Whitlock Jr, J. P. (1986). The regulation of cytochrome P-450 gene expression. Annual review of pharmacology and toxicology, 26(1), 333-369.
Horsfall Jr, F. L. (1963). Current concepts of cancer. Canadian Medical Association journal, 89(24), 1224.
Kovacic, P., & Somanathan, R. (2014). Nitroaromatic compounds: Environmental toxicity, carcinogenicity, mutagenicity, therapy and mechanism. Journal of Applied Toxicology, 34(8), 810-824.
Mital, A. (2009). Synthetic nitroimidazoles: biological activities and mutagenicity relationships. Scientia pharmaceutica, 77(3), 497-520.
Gatnik, M. F. (2016). Computational Methods in Support of Chemical Risk Assessment. Liverpool John Moores University (United Kingdom).
Dayan, A. D. (1993). Allergy to antimicrobial residues in food: assessment of the risk to man. Veterinary microbiology, 35(3-4), 213-226.
Quan, S. F., Howard, B. V., Iber, C., Kiley, J. P., Nieto, F. J., O'Connor, G. T., ... & Wahl, P. W. (1997). The sleep heart health study: design, rationale, and methods. Sleep, 20(12), 1077-1085.
Setia, M. S. (2016). Methodology series module 1: Cohort studies. Indian journal of dermatology, 61(1), 21.
Amine, B. (2021). STATISTICS & MEDICINE: THE EXACT LINK. Global Journal of Public Health Medicine, 3(2), 409-413.
Petrelli, F., Ghidini, M., Ghidini, A., Perego, G., Cabiddu, M., Khakoo, S., ... & Zaniboni, A. (2019). Use of antibiotics and risk of cancer: a systematic review and meta-analysis of observational studies. Cancers, 11(8), 1174.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
